Molecular Pharmacology: 50 (3)

September 01, 1996; Volume 50,Issue 3

You have access
Piperonyl butoxide and acenaphthylene induce cytochrome P450 1A2 and 1B1 mRNA in aromatic hydrocarbon-responsive receptor knock-out mouse liver.
D Y Ryu, P E Levi, P Fernandez-Salguero, F J Gonzalez and E Hodgson

Molecular Pharmacology September 1996, 50 (3) 443-446;
You have access
Functional selectivity of orphanin FQ for its receptor coexpressed with potassium channel subunits in Xenopus laevis oocytes.
H Matthes, E P Seward, B Kieffer and R A North

Molecular Pharmacology September 1996, 50 (3) 447-450;
You have access
Structural requirements of sphingosylphosphocholine and sphingosine-1-phosphate for stimulation of activator protein-1 activity.
A Berger, R Bittman, R R Schmidt and S Spiegel

Molecular Pharmacology September 1996, 50 (3) 451-457;
You have access
Pharmacological properties of gamma-aminobutyric acidA receptors from acutely dissociated rat dentate granule cells.
J Kapur and R L Macdonald

Molecular Pharmacology September 1996, 50 (3) 458-466;
You have access
A fully active nonglycosylated V2 vasopressin receptor.
G Innamorati, H Sadeghi and M Birnbaumer

Molecular Pharmacology September 1996, 50 (3) 467-473;
You have access
Role of heme in cytochrome P450 transcription and function in mice treated with lead acetate.
R Jover, R L Lindberg and U A Meyer

Molecular Pharmacology September 1996, 50 (3) 474-481;
You have access
BIBW22 BS, potent multidrug resistance-reversing agent, binds directly to P-glycoprotein and accumulates in drug-resistant cells.
Z Liu, F Lheureux, J F Pouliot, A Heckel, U Bamberger and E Georges

Molecular Pharmacology September 1996, 50 (3) 482-492;
You have access
Constitutive activation of a phosphoinositidase C-linked G protein in murine fibroblasts decreases agonist-stimulated Ca2+ mobilization.
L A Lobaugh, B Eisfelder, K Gibson, G L Johnson and J W Putney

Molecular Pharmacology September 1996, 50 (3) 493-500;
You have access
D-penicillamine causes free radical-dependent inactivation of activator protein-1 DNA binding.
M L Handel, C K Watts, S Sivertsen, R O Day and R L Sutherland

Molecular Pharmacology September 1996, 50 (3) 501-505;
You have access
Calcineurin mutants render T lymphocytes resistant to cyclosporin A.
D Zhu, M E Cardenas and J Heitman

Molecular Pharmacology September 1996, 50 (3) 506-511;
You have access
Hydrophilic side chains in the third and seventh transmembrane helical domains of human A2A adenosine receptors are required for ligand recognition.
Q Jiang, A M Van Rhee, J Kim, S Yehle, J Wess and K A Jacobson

Molecular Pharmacology September 1996, 50 (3) 512-521;
You have access
Angiotensin II type 1 receptor signals through Raf-1 by a protein kinase C-dependent, Ras-independent mechanism.
H Arai and J A Escobedo

Molecular Pharmacology September 1996, 50 (3) 522-528;
You have access
Studies on alpha v beta 3/ligand interactions using a [3H]SK&F-107260 binding assay.
A Wong, S M Hwang, P McDevitt, D McNulty, J M Stadel and K Johanson

Molecular Pharmacology September 1996, 50 (3) 529-537;
You have access
Trans-activation by the human aryl hydrocarbon receptor and aryl hydrocarbon receptor nuclear translocator proteins: direct interactions with basal transcription factors.
J C Rowlands, I J McEwan and J A Gustafsson

Molecular Pharmacology September 1996, 50 (3) 538-548;
You have access
Cyclic AMP-dependent phosphodiesterase isozyme-specific potentiation by protein kinase C in hypertrophic cardiomyopathic hamster hearts.
H Yu, J J Cai and H C Lee

Molecular Pharmacology September 1996, 50 (3) 549-555;
You have access
Okadaic acid potentiates 3-methylcholanthrene-induced CYP2A8 gene expression in primary cultures of Syrian hamster hepatocytes: possible involvement of activator protein-1.
M Tohkin, K Kurose and M Fukuhara

Molecular Pharmacology September 1996, 50 (3) 556-564;
You have access
Ontogeny and hormonal basis of male-dominant rat hepatic sulfotransferases.
L Liu and C D Klaassen

Molecular Pharmacology September 1996, 50 (3) 565-572;
You have access
Cytochrome P450 2E1 is a cell surface autoantigen in halothane hepatitis.
E Eliasson and J G Kenna

Molecular Pharmacology September 1996, 50 (3) 573-582;
You have access
Morphine down-regulates melanocortin-4 receptor expression in brain regions that mediate opiate addiction.
J D Alvaro, J B Tatro, J M Quillan, M Fogliano, M Eisenhard, M R Lerner, E J Nestler and R S Duman

Molecular Pharmacology September 1996, 50 (3) 583-591;
You have access
Quinone thioether-mediated DNA damage, growth arrest, and gadd153 expression in renal proximal tubular epithelial cells.
J K Jeong, J L Stevens, S S Lau and T J Monks

Molecular Pharmacology September 1996, 50 (3) 592-598;
You have access
The stimulatory effect of opioids on mitogen-activated protein kinase in Chinese hamster ovary cells transfected to express mu-opioid receptors.
L Y Li and K J Chang

Molecular Pharmacology September 1996, 50 (3) 599-602;
You have access
Biochemical and pharmacological activity of novel 8-fluoroanthracyclines: influence of stereochemistry and conformation.
F Animati, F Arcamone, M Bigioni, G Capranico, C Caserini, M De Cesare, P Lombardi, G Pratesi, C Salvatore, R Supino and F Zunino

Molecular Pharmacology September 1996, 50 (3) 603-609;
You have access
Induction of apoptosis by benzene metabolites in HL60 and CD34+ human bone marrow progenitor cells.
J L Moran, D Siegel, X M Sun and D Ross

Molecular Pharmacology September 1996, 50 (3) 610-615;
You have access
N-palmitoyl-serine and N-palmitoyl-tyrosine phosphoric acids are selective competitive antagonists of the lysophosphatidic acid receptors.
K Liliom, R Bittman, B Swords and G Tigyi

Molecular Pharmacology September 1996, 50 (3) 616-623;
You have access
Direct evidence for functional coupling of the vasoactive intestinal peptide receptor to Gi3 in native lung membranes.
N L Diehl, J C Kermode and S M Shreeve

Molecular Pharmacology September 1996, 50 (3) 624-630;
You have access
Use of subunit-specific antisense oligodeoxynucleotides to define developmental changes in the properties of N-methyl-D-aspartate receptors.
J Zhong, V K Gribkoff and P B Molinoff

Molecular Pharmacology September 1996, 50 (3) 631-638;
You have access
Interactions of oxime reactivators with diethylphosphoryl adducts of human acetylcholinesterase and its mutant derivatives.
H Grosfeld, D Barak, A Ordentlich, B Velan and A Shafferman

Molecular Pharmacology September 1996, 50 (3) 639-649;
You have access
The mu-opioid receptor antagonist D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2 (CTOP) [but not D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 (CTAP)] produces a nonopioid receptor-mediated increase in K+ conductance of rat locus ceruleus neurons.
B Chieng, M Connor and M J Christie

Molecular Pharmacology September 1996, 50 (3) 650-655;
You have access
Detection of alpha-hydroxyethyl free radical adducts in the pancreas after chronic exposure to alcohol in the rat.
Y Iimuro, B U Bradford, W Gao, M Kadiiska, R P Mason, B Stefanovic, D A Brenner and R G Thurman

Molecular Pharmacology September 1996, 50 (3) 656-661;
You have access
Agonist-induced modulation of inverse agonist efficacy at the beta 2-adrenergic receptor.
P Chidiac, S Nouet and M Bouvier

Molecular Pharmacology September 1996, 50 (3) 662-669;
You have access
Functional characterization of human gamma-aminobutyric acidA receptors containing the alpha 4 subunit.
K A Wafford, S A Thompson, D Thomas, J Sikela, A S Wilcox and P J Whiting

Molecular Pharmacology September 1996, 50 (3) 670-678;
You have access
125I-Tyro-sauvagine: a novel high affinity radioligand for the pharmacological and biochemical study of human corticotropin-releasing factor 2 alpha receptors.
D E Grigoriadis, X J Liu, J Vaughn, S F Palmer, C D True, W W Vale, N Ling and E B De Souza

Molecular Pharmacology September 1996, 50 (3) 679-686;
You have access
Mercury binding site on Na+/K(+)-ATPase: a cysteine in the first transmembrane segment.
X Wang and J D Horisberger

Molecular Pharmacology September 1996, 50 (3) 687-691;
You have access
Repetitive endocytosis and recycling of the beta 2-adrenergic receptor during agonist-induced steady state redistribution.
K J Morrison, R H Moore, N D Carsrud, J Trial, E E Millman, M Tuvim, R B Clark, R Barber, B F Dickey and B J Knoll

Molecular Pharmacology September 1996, 50 (3) 692-699;

Main menu

User menu

Search

Table of Contents

In this issue

Navigate

More Information

ASPET's Other Journals